atenolol has been researched along with Vascular Diseases in 3 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, H | 1 |
| Averill, DB | 1 |
| Brosnihan, KB | 1 |
| Smith, RD | 1 |
| Schiffrin, EL | 1 |
| Ferrario, CM | 1 |
| Coutard, M | 1 |
| Osborne-Pellegrin, M | 1 |
1 trial available for atenolol and Vascular Diseases
| Article | Year |
|---|---|
Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.
Topics: Aged; Atenolol; Blood Pressure; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transien | 1993 |
2 other studies available for atenolol and Vascular Diseases
| Article | Year |
|---|---|
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; | 2005 |
Rupture of the internal elastic lamina and vascular fragility in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arteries; Atenolol; Blood Pressure; Capillary Fragility; Captopril; Cerebrovascular Disorde | 1991 |